175 related articles for article (PubMed ID: 31165160)
1. The Trials (and Tribulations) of Complementary and Alternative Medicine in Oncology.
Ludmir EB; Jethanandani A; Mainwaring W; Miller AB; Lin TA; Espinoza AF; Verma V; VanderWalde NA; Grossberg AJ; Guadagnolo BA; Koong AC; Jagsi R; Thomas CR; Fuller CD
J Natl Cancer Inst; 2019 Dec; 111(12):1358-1360. PubMed ID: 31165160
[TBL] [Abstract][Full Text] [Related]
2. Characteristic Analysis of Complementary and Alternative Medicine in Randomized Controlled Trials of Oncology: A Comparison of Published Studies.
Zhang H; Yang G; Zhang W; Gu W; Su Y; Ling C
Integr Cancer Ther; 2018 Jun; 17(2):551-557. PubMed ID: 28627237
[TBL] [Abstract][Full Text] [Related]
3. Discrepant views of oncologists and cancer patients on complementary/alternative medicine.
Richardson MA; Mâsse LC; Nanny K; Sanders C
Support Care Cancer; 2004 Nov; 12(11):797-804. PubMed ID: 15378417
[TBL] [Abstract][Full Text] [Related]
4. Cancer complementary and alternative medicine research at the US National Cancer Institute.
Jia L
Chin J Integr Med; 2012 May; 18(5):325-32. PubMed ID: 22241505
[TBL] [Abstract][Full Text] [Related]
5. Methodological quality of patient-reported outcome research was low in complementary and alternative medicine in oncology.
Efficace F; Horneber M; Lejeune S; Van Dam F; Leering S; Rottmann M; Aaronson NK
J Clin Epidemiol; 2006 Dec; 59(12):1257-65. PubMed ID: 17098568
[TBL] [Abstract][Full Text] [Related]
6. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.
Buchanan DR; White JD; O'Mara AM; Kelaghan JW; Smith WB; Minasian LM
J Clin Oncol; 2005 Sep; 23(27):6682-9. PubMed ID: 16170176
[TBL] [Abstract][Full Text] [Related]
7. Clinical trials in cancer. Part I. Biomedical, complementary, and alternative medicine: finding active trials and results of closed trials.
Lee CO
Clin J Oncol Nurs; 2004 Oct; 8(5):531-5. PubMed ID: 15515286
[TBL] [Abstract][Full Text] [Related]
8. New opportunities and proven approaches in complementary and alternative medicine research at the National Institutes of Health.
Harlan WR
J Altern Complement Med; 2001; 7 Suppl 1():S53-9. PubMed ID: 11822636
[TBL] [Abstract][Full Text] [Related]
9. Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants.
Freeman MP; Mischoulon D; Tedeschini E; Goodness T; Cohen LS; Fava M; Papakostas GI
J Clin Psychiatry; 2010 Jun; 71(6):682-8. PubMed ID: 20573327
[TBL] [Abstract][Full Text] [Related]
10. Differences in Funding Sources of Phase III Oncology Clinical Trials by Treatment Modality and Cancer Type.
Jairam V; Yu JB; Aneja S; Wilson LD; Lloyd S
Am J Clin Oncol; 2017 Jun; 40(3):312-317. PubMed ID: 25374144
[TBL] [Abstract][Full Text] [Related]
11. Testing complementary and alternative therapies within a research protocol.
Walker LG; Anderson J
Eur J Cancer; 1999 Oct; 35(11):1614-8. PubMed ID: 10673971
[TBL] [Abstract][Full Text] [Related]
12. N-of-1 trials: innovative methods to evaluate complementary and alternative medicines in pediatric cancer.
Sung L; Feldman BM
J Pediatr Hematol Oncol; 2006 Apr; 28(4):263-6. PubMed ID: 16679928
[TBL] [Abstract][Full Text] [Related]
13. Complementary and alternative medicine research and cooperative groups: can it happen?
O'Mara A
J Pediatr Oncol Nurs; 2006; 23(5):258-60. PubMed ID: 16902079
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of insomnia and complementary medicine.
Sarris J; Byrne GJ
Sleep Med Rev; 2011 Apr; 15(2):99-106. PubMed ID: 20965131
[TBL] [Abstract][Full Text] [Related]
15. Complementary and Alternative Medicine Therapies for Psoriasis: A Systematic Review.
Gamret AC; Price A; Fertig RM; Lev-Tov H; Nichols AJ
JAMA Dermatol; 2018 Nov; 154(11):1330-1337. PubMed ID: 30193251
[TBL] [Abstract][Full Text] [Related]
16. A comparison of complementary and alternative medicine use by gynecology and gynecologic oncology patients.
Von Gruenigen VE; White LJ; Kirven MS; Showalter AL; Hopkins MP; Jenison EL
Int J Gynecol Cancer; 2001; 11(3):205-9. PubMed ID: 11437926
[TBL] [Abstract][Full Text] [Related]
17. Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the National Cancer Institute-sponsored cooperative oncology groups, 1955 to 2006.
Djulbegovic B; Kumar A; Soares HP; Hozo I; Bepler G; Clarke M; Bennett CL
Arch Intern Med; 2008 Mar; 168(6):632-42. PubMed ID: 18362256
[TBL] [Abstract][Full Text] [Related]
18. Complementary and alternative medicine use among US cancer survivors.
John GM; Hershman DL; Falci L; Shi Z; Tsai WY; Greenlee H
J Cancer Surviv; 2016 Oct; 10(5):850-64. PubMed ID: 26920872
[TBL] [Abstract][Full Text] [Related]
19. Factors Associated With Age Disparities Among Cancer Clinical Trial Participants.
Ludmir EB; Mainwaring W; Lin TA; Miller AB; Jethanandani A; Espinoza AF; Mandel JJ; Lin SH; Smith BD; Smith GL; VanderWalde NA; Minsky BD; Koong AC; Stinchcombe TE; Jagsi R; Gomez DR; Thomas CR; Fuller CD
JAMA Oncol; 2019 Dec; 5(12):1769-1773. PubMed ID: 31158272
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of complementary and alternative medicine interventions for the management of cancer-related fatigue.
Finnegan-John J; Molassiotis A; Richardson A; Ream E
Integr Cancer Ther; 2013 Jul; 12(4):276-90. PubMed ID: 23632236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
